Atlas Trials

Efficacy of MEMORMAX in Subjects With MCI

Clinical trial NCT03581929 · COMPLETED

Trial details

NCT number
NCT03581929
Sponsor
Aboca Spa Societa' Agricola
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2017-11-20
Primary completion
2019-12-19
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.